Background: It has been reported that ginger is involved in serotonergic system. It seems that ginger effect could be attributed to its active compound or gingerol. The present study was conducted to evaluate the effects of gingerol on antidepressant-like effects by investigation of serotonergic system in mice model.
Introduction
ajor depressive disorder has been known a complex psychiatric disorder with unknown cause which will involve up to 20% of the individuals during their lifetime [1] and it causes disability in people [2] . It has been disorders [5, 6] which could be attributed to excessive oxygen consumption and lipid-rich compounds of the brain [7, 8] . Studies have related depression with faulted antioxidative enzyme activities [9] [10] [11] .
The faulted antioxidant system could reduce the protection against Reactive Oxygen Species (ROS) [9] . Elevated ROS in depression has been related with increased levels of malondialdehyde and arachidonic acid [9] . It has been reported increased oxidative stress in the rats exposed to stress [12] . These evidences suggest therapeutic activity of antioxidant compounds for treatment of depression [13] . 6-Gingerol is known as one phenolic compound which is found in some plants in Zingiberaceae family including ginger, cardamom and grain of paradise. It has been known to have some properties such as cognitive enhancer [14] , anti-apoptotic [15] , antioxidant and anti-inflammatory [16] .
It has been reported effect of ginger on gastric similar to metoclopramide, a 5-HT 4 receptor agonist with antagonist properties at 5-HT 3 receptors through a selective 5-HT 3 receptor antagonist [17, 18] . This study was thus conducted to evaluate the antidepressant-like activity of gingerol in mice model.
Materials and Methods

Materials
Gingerol powder and DMSO (Dimethyl sulphoxide) were purchased from Chromadex (Santa Ana, CA, USA) and Scharlo (Spain), respectively. 
Acute toxicity test
Previous procedures were used to evaluate the acute toxicity test [19] . Following 24 h food restriction, 24 mice were divided into 4 groups and intrapritoeanally received 200, 400, 800 and 1200 mg/kg gingerol dissolved in DMSO. Following treatment, animals were considered for some toxicity signs and behavioral symptoms including locomotor activity, changes in physical appearance respiratory distress, coma, and mortality for 72 h. This action was conducted for 10 days and to be healthiness and mortality were recorded [20] . We did not observe any mortality and only dizziness was observed in levels of 800-1200 mg/kg. Thus, we selected levels of 100 and 300 mg/kg for future studies.
Tail suspension test
Tail suspension test was conducted as reported by previous studies and total period of immobility was considered as reported by previous studies [21] . Animals were divided into 4 groups with 6 mice and treated by follow protocol: 1. Vehicle group= mice intra pritoeanally received normal saline (10 ml/kg); 2 and 3. G-100, and G-200, mice intrapritoeanally received 100 and 200 mg/ kg gingerol; and 4. Fluoxetine= mice intra pritoeanally received 20 mg/kg fluoxetine. To evaluate the tail suspension test, total period of immobility time was registered by using a chronometer. Decreased immobility time was considered as a criteria for antidepressant activity [22, 23] .
Evaluation of serotonergic system in the antidepressant-like effect of gingerol
To investigate the serotonergic system, pre-treatment with PCPA, blocker of 5HT synthesis, was conducted (once/d for 3consecutive days). Since the best responses were observed in 300 mg/kg gingerol, same dose was used in future trials. Following pre-treatment with PCPA, animals were treated with 300 mg/kg gingerol, 15 min after last administration of PCPA. Animals were submitted to tail suspension test after administration of gingerol [24] . To evaluate the involvement of 5HT1 receptor, mice were pre-treated with WAY100135 (10 mg/kg), treated with 300 mg/kg gingerol60 min after pre-treatment and exposed to tail suspension test after administration of gingerol [25] . To assess the involvement the 5HT2 receptor, animals were pre-treated with ketanserin and cyproheptadine, treated with 300 mg/kg gingerol 60 min after pre-treatment and finally submitted to ail suspension test [26, 27] .
Open Field Test (OFT)
To evaluate the psychomotor stimulant activity, OFT was conducted as reported by others [28] . Each mouse was grouped in Plexiglas boxes (40×60×50 cm). All the crossings and rearing were registered. We considered crossing as locomotors activity and rearing as exploratory behavior.
Statistical analysis
The data were reported as mean± standard deviation (Mean±SD) and analyzed by one-way Analysis of Variance (ANOVA) and Two-was analysis. Tukey post-hoc test was used to comparethe groups. A level of P<0.05 was considered as significant. The figures were illustrated by Prism, version 7 (GraphPad Software, Inc., San Diego, CA, USA).
Results
Our findings for tail suspension test are shown in Figure 1 . Results showed that administration of gingerol could significantly decrease immobility time (P<0.05). Immobility was decreased with increasing dose, so that lowest immobility time was observed in mice administrated with 300 mg gingerol. There was no significant difference between fluoextine with 300 mg gingerol.
The data for pretreatment of mice with pCPA (preventer of serotonin synthesis), WAY100135 (receptor antagonist), ketanserin (5HT2A receptor antagonist), and cyproheptadine (5HT2 receptor antagonist) in antidepressant-like effect induced by gingerol in tail suspension test are Figure 2 . As results show pretreatments significantly prevented the antidepressant-like effect induced by the gingerol. Our findings for OFT are shown in Figure 3 . Results showed that number of OFT was not different among different groups (P>0.05).
Discussion
The present results showed that use of the gingerol as an antidepressant agent could express antidepressantlike activity in tail suspension test in mice. Tail suspension test has been known as one behavioral model for detection of antidepressant activity. In the model, decreased immobility time were considered as an indicator for antidepressant-like action [29] . Tail suspension test has been used to evaluate the depressive-like behaviors in mice because it could imitate helpless behaviors that frequently seen in patients with depression [30] . We did not observe differences for immobility time. Increased locomotor activity could be considered as false response. We could not find in the published literature any study to show antidepressant activity of gingerol.
With regards to our findings, it showed antidepressantlike effect of gingerol by modulation in serotonin system. The data for acute mechanism of antidepressant drugs caused to be considered by monoaminergic system [31] . The monoamine pathways such as serotonergic transmission have been known as target site for antidepressant drugs [32] .
It has been accepted more or less that most of the drugs administrated for treatment of depression is involved in monoamine neurotransmitters [33] . However, pretreatment with pCPA (preventer of serotonin synthesis), WAY100135 (receptor antagonist), ketanserin (5HT2A receptor antagonist), and cyproheptadine (5HT2 receptor antagonist) could prevent decreased immobility period induced by gingerol. It means that serotonergic system is involved in the antidepressant effects of gingerol in the tail suspension test in the mice. Previous studies have shown the role of 5HT as one neurotransmitter in depression, because it is involved in some symptoms of major depression [34] .
Other reason is that 5HT1A receptors clearly modulate in the clinical effect of antidepressants [35] due to its position in the soma and dendrites of 5HT neurons in the dorsal raphe which inhibit to release 5HT [36] . Previous studies have also reported that ketanserin could prevent antidepressant activity in some herbal medicines in the tail suspension test in the animal model [33, 37] . It has been known tryptophan as substrate for synthesis of serotonin. We believed that gingerol could partly prevent oxidation of tryptophandue to its antioxidant properties. Unfortunately, we could not find any published study in the literature which showing effects of gingerol on serotonergic system.
Conclusion
In summary, it could be stated that gingerol could be involved in serotonergic system and show antidepressantlike effect. We suggest touse the gingerol for treatment of depression as a novel agent in commercial preparation and prescribed as a drug for therapeutic reasons.
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